Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
Tax Provision
Glenmark Life Sciences Ltd
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Tax Provision
-₹1.6B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Tax Provision
-₹16.2B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Tax Provision
-₹15.5B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-13%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Tax Provision
-₹15.1B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-6%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Tax Provision
-₹7.9B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-52%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Tax Provision
-₹6.5B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-85%
|
CAGR 10-Years
-15%
|
See Also
What is Glenmark Life Sciences Ltd's Tax Provision?
Tax Provision
-1.6B
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Tax Provision amounts to -1.6B INR.
What is Glenmark Life Sciences Ltd's Tax Provision growth rate?
Tax Provision CAGR 5Y
-37%
Over the last year, the Tax Provision growth was 1%. The average annual Tax Provision growth rates for Glenmark Life Sciences Ltd have been -10% over the past three years , -37% over the past five years .